Tilray Brands, Inc. (2HQ.DE)
EUR 0.41
(-3.15%)
EUR 0.41
(-3.15%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.22 Billion USD | -1.99% |
| 2022 | 4.3 Billion USD | -20.96% |
| 2021 | 5.44 Billion USD | -9.55% |
| 2020 | 6.02 Billion USD | 234.51% |
| 2019 | 1.8 Billion CAD | -0.19% |
| 2018 | 1.8 Billion CAD | 77.08% |
| 2017 | 1.01 Billion CAD | 334.5% |
| 2016 | 234.54 Million CAD | 743.18% |
| 2015 | 27.81 Million CAD | 141.87% |
| 2014 | 11.5 Million CAD | 6690.7% |
| 2013 | 169.35 Thousand CAD | -40.0% |
| 2012 | 282.27 Thousand CAD | -18.0% |
| 2011 | 344.22 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 4.26 Billion USD | 2.21% |
| 2023 Q3 | 4.21 Billion USD | -2.72% |
| 2023 Q4 | 4.22 Billion USD | 0.21% |
| 2023 FY | 4.22 Billion USD | -1.99% |
| 2023 Q1 | 4.4 Billion USD | 2.21% |
| 2023 Q2 | 4.33 Billion USD | -1.63% |
| 2022 Q3 | 4.37 Billion USD | -20.07% |
| 2022 Q1 | 5.59 Billion USD | 2.62% |
| 2022 FY | 4.3 Billion USD | -20.96% |
| 2022 Q4 | 4.3 Billion USD | -1.57% |
| 2022 Q2 | 5.47 Billion USD | -2.11% |
| 2021 Q3 | 5.81 Billion USD | 0.97% |
| 2021 Q1 | 5.98 Billion USD | -0.65% |
| 2021 FY | 5.44 Billion USD | -9.55% |
| 2021 Q4 | 5.44 Billion USD | -6.35% |
| 2021 Q2 | 5.76 Billion USD | -3.72% |
| 2020 FY | 6.02 Billion USD | 234.51% |
| 2020 Q2 | 2.16 Billion USD | 13.71% |
| 2020 Q3 | 2.2 Billion CAD | 1.7% |
| 2020 Q4 | 6.02 Billion USD | 173.68% |
| 2020 Q1 | 1.9 Billion USD | 5.69% |
| 2019 FY | 1.8 Billion CAD | -0.19% |
| 2019 Q3 | 1.94 Billion USD | 3.7% |
| 2019 Q2 | 1.87 Billion USD | 2.87% |
| 2019 Q4 | 1.8 Billion USD | -7.26% |
| 2019 Q1 | 1.82 Billion USD | 0.9% |
| 2018 Q1 | 1.25 Billion USD | 22.83% |
| 2018 Q2 | 1.58 Billion USD | 26.26% |
| 2018 Q4 | 1.8 Billion USD | 15.58% |
| 2018 Q3 | 1.56 Billion USD | -1.21% |
| 2018 FY | 1.8 Billion CAD | 77.08% |
| 2017 Q3 | 668.99 Million USD | 95.84% |
| 2017 Q2 | 341.59 Million USD | 30.23% |
| 2017 Q1 | 262.3 Million CAD | 11.84% |
| 2017 FY | 1.01 Billion CAD | 334.5% |
| 2017 Q4 | 1.01 Billion USD | 52.33% |
| 2016 Q4 | 234.54 Million CAD | 52.48% |
| 2016 Q2 | 103.24 Million CAD | 63.87% |
| 2016 Q1 | 63 Million CAD | 126.5% |
| 2016 FY | 234.54 Million CAD | 743.18% |
| 2016 Q3 | 153.81 Million CAD | 48.98% |
| 2015 FY | 27.81 Million CAD | 141.87% |
| 2015 Q1 | 10.95 Million CAD | -4.73% |
| 2015 Q2 | 10.75 Million CAD | -1.88% |
| 2015 Q3 | 21.59 Million CAD | 100.93% |
| 2015 Q4 | 27.81 Million CAD | 28.78% |
| 2014 Q4 | 11.5 Million CAD | -0.72% |
| 2014 FY | 11.5 Million CAD | 6690.7% |
| 2014 Q3 | 11.58 Million CAD | 7369.4% |
| 2014 Q2 | 155.08 Thousand CAD | -8.43% |
| 2014 Q1 | 169.35 Thousand CAD | -32.28% |
| 2013 Q1 | 282.27 Thousand CAD | -2.28% |
| 2013 FY | 169.35 Thousand CAD | -40.0% |
| 2013 Q4 | 250.06 Thousand CAD | 0.79% |
| 2013 Q3 | 248.09 Thousand CAD | -9.38% |
| 2013 Q2 | 273.76 Thousand CAD | -3.01% |
| 2012 FY | 282.27 Thousand CAD | -18.0% |
| 2012 Q1 | 344.22 Thousand CAD | -1.39% |
| 2012 Q2 | 344.34 Thousand CAD | 0.03% |
| 2012 Q3 | 306.77 Thousand CAD | -10.91% |
| 2012 Q4 | 288.86 Thousand CAD | -5.84% |
| 2011 FY | 344.22 Thousand CAD | 0.0% |
| 2011 Q4 | 349.07 Thousand CAD | -4.88% |
| 2011 Q2 | 141.7 Thousand CAD | 0.0% |
| 2011 Q3 | 366.96 Thousand CAD | 158.96% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| MPH Health Care AG | 266.35 Million EUR | -1484.991% |
| Apontis Pharma AG | 57.5 Million EUR | -7242.026% |
| Dermapharm Holding SE | 2.18 Billion EUR | -93.344% |
| Evotec SE | 2.29 Billion EUR | -83.626% |
| MERCK Kommanditgesellschaft auf Aktien | 49.12 Billion EUR | 91.406% |
| PharmaSGP Holding SE | 131.29 Million EUR | -3115.306% |
| SynBiotic SE | 34.91 Million EUR | -11990.169% |